Targeting Alpha-Synuclein: Breakthroughs in the Quest to Halt Parkinson's Progression

The Odyssey of Alpha-synuclein and Neuroinflammatory Mediators as Potential Candidates in the Aetiology of Parkinson's Disease

Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery

Frontiers Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease

α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations - ScienceDirect

Frontiers Parkinson's Disease: A Nanotheranostic Approach Targeting Alpha- Synuclein Aggregation

Frontiers Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough

The Odyssey of Alpha-synuclein and Neuroinflammatory Mediators as Potential Candidates in the Aetiology of Parkinson's Disease

Pharmaceutics, Free Full-Text

PDF) Alpha-synuclein oligomers: a new hope

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations - ScienceDirect